• SENSEX
    NIFTY 50
Healthcare

Pfizer-Mylan deal will not impact Biocon's business, says CMD Kiran Mazumdar Shaw

Updated : July 30, 2019 08:57 AM IST

Had indicated looking at pursuing biosimilar opportunity independently: Shaw
Pfizer's biosimilar portfolio is not parked with Upjohn: Shaw

You May Also Like

Live TV
Advertisement